Skip to main content

Table 1 Changes over time by treatment arm

From: Scaling-up from an implementation trial to state-wide coverage: results from the preliminary Melbourne Diabetes Prevention Study

 

Intervention

Control

Intervention vs. control

  

Baseline

Δ3 months

Δ12 months

 

Baseline

Δ12 months

Δ12 months

 

n

Mean (SD)

Mean (SE)

Mean (SE)

n

Mean (SD)

Mean (SE)

Mean (SE)

P value

BMI (kg/m2)

38

31.4 (4.82)

−0.86 (0.15)*

−0.98 (0.26)*

41

30.1 (4.19)

−0.21 (0.12)

−0.77 (0.29)

<0.001

Weight (kg)

38

87.2 (12.5)

−2.38 (0.40)*

−2.65 (0.72)*

41

81.8 (14.4)

−0.60 (0.33)

−2.05 (0.79)

0.844

Waist (cm)

38

106.5 (8.35)

−5.04 (1.00)*

−7.45 (1.15)*

41

101.7 (11.52)

−4.02 (0.95)*

−3.42 (1.48)

0.334

Hip (cm)

38

112.7 (9.24)

−1.97 (0.88)*

−3.18 (1.26)*

41

110.8 (9.90)

0.37 (1.05)

−3.56 (1.63)

0.348

SBP (mmHg)

38

135.9 (18.61)

−6.63 (2.25)*

−6.55 (2.39)*

41

132.1 (14.04)

−0.45 (2.86)

−6.10 (3.75)

0.126

DBP (mmHg)

38

80.1 (7.85)

−1.25 (1.31)

0.70 (1.55)

41

78.4 (7.84)

1.43 (1.75)

−0.73 (2.35)

0.963

TC (mmol/l)

37

4.97 (1.15)

−0.08 (0.10)

−0.09 (0.12)

39

5.05 (0.88)

0.06 (0.15)

−0.15 (0.19)

0.225

TG (mmol/l)

37

1.41 (0.50)

−0.07 (0.12)

−0.09 (0.08)

39

1.44 (0.64)

0.01 (0.08)

−0.10 (0.11)

0.227

HDL-cholesterol (mmol/l)

37

1.43 (0.35)

0.01 (0.03)

0.07 (0.03)*

39

1.59 (0.48)

−0.05 (0.04)

0.12 (0.05)

0.259

LDL-cholesterol (mmol/l)

37

2.89 (1.01)

0.11 (0.15)

−0.12 (0.11)

39

2.79 (0.84)

0.11 (0.12)

−0.23 (0.17)

0.207

FPG (mmol/l)

37

5.17 (0.44)

−0.07 (0.08)

−0.03 (0.06)

39

5.17 (0.44)

0.05 (0.07)

−0.08 (0.10)

0.219

2-hour OGTT (mmol/l)

36

6.64 (1.76)

n/a

−0.11 (0.30)

37

6.08 (1.50)

0.59 (0.27)*

−0.70 (0.40)

0.232

HbA1c (%)

37

5.86 (0.30)

−0.05 (0.03)

0.08 (0.07)

39

5.89 (0.33)

0.13 (0.08)

−0.05 (0.11)

0.218

HADS-A

38

6.08 (3.35)

−0.53 (0.45)

−0.68 (0.38)

41

5.15 (3.18)

0.08 (0.34)

−0.76 (0.51)

0.467

HADS-D

38

3.16 (2.35)

0.03 (0.36)

0.18 (0.34)

41

2.90 (2.84)

0.02 (0.27)

0.17 (0.43)

0.876

Total fat (%)

33

36.3 (4.45)

n/a

−2.01 (0.83)*

37

36.2 (4.51)

−0.42 (0.77)

−1.59 (1.13)

0.290

Saturated fat (%)

33

14.6 (3.25)

n/a

−1.64 (0.51)*

37

14.0 (2.93)

0.29 (0.38)

−1.94 (0.62)

0.088

Fibre (g/day)

33

13.6 (2.97)

n/a

1.95 (0.58)*

37

13.5 (3.32)

0.51 (0.47)

1.45 (0.75)

0.030

  1. Δ, change over time; SD, standard deviation; SE, standard error; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test glucose level; HbA1c, glycated haemoglobin; HADS-A, Hospital Anxiety and Depression Scale anxiety score; HADS-D, Hospital Anxiety and Depression Scale depression score; Total fat, percentage energy from total fat; saturated fat, percentage energy from saturated fat; fibre, grams of fibre per 1,000 kilocalories of energy; n/a, not measured at 3 months. *P%20<0.05 for within-group comparison.